title: Infusion of rituximab over 90 minutes on an out-patient basis is safe and improves resource utilization.
authors.forename: Moulod R
authors.initials: MR
authors.lastname: El-Agnaf
authors.forename: Cathy
authors.initials: C
authors.lastname: McCoy
authors.forename: Young-Lee
authors.initials: YL
authors.lastname: Ong
authors.forename: Abdul-Hakeem
authors.initials: AH
authors.lastname: Eswedi
authors.forename: Barbra
authors.initials: B
authors.lastname: Black
authors.forename: Khaled M
authors.initials: KM
authors.lastname: Ramadan
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D013997:Time Factors